{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:08:42Z","timestamp":1792663722684,"version":"4.5.0"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["31003A-134926"],"award-info":[{"award-number":["31003A-134926"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007364","name":"Fondazione CRT","doi-asserted-by":"publisher","award":["RF=2016.2780"],"award-info":[{"award-number":["RF=2016.2780"]}],"id":[{"id":"10.13039\/100007364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004784","name":"Novartis Stiftung\u00a0f\u00fcr\u00a0Medizinisch-Biologische Forschung","doi-asserted-by":"publisher","award":["18A053"],"award-info":[{"award-number":["18A053"]}],"id":[{"id":"10.13039\/501100004784","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jsbmb.2019.105507","type":"journal-article","created":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T12:44:19Z","timestamp":1571921059000},"page":"105507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Differential effects of variations in human P450 oxidoreductase on the aromatase activity of CYP19A1 polymorphisms R264C and R264H"],"prefix":"10.1016","volume":"196","author":[{"given":"Shaheena","family":"Parween","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"DiNardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Baj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Gilardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit V.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jsbmb.2019.105507_bib0005","first-page":"342","article-title":"Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis","volume":"15","author":"Simpson","year":"1994","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.jsbmb.2019.105507_bib0010","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1210\/jcem-72-3-560","article-title":"A new cause of female pseudohermaphroditism: placental aromatase deficiency","volume":"72","author":"Shozu","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.jsbmb.2019.105507_bib0015","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1016\/S0021-9258(18)42900-6","article-title":"Biochemical and molecular genetic analyses on placental aromatase (P-450AROM) deficiency","volume":"267","author":"Harada","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105507_bib0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.jsbmb.2019.105507_bib0025","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.bbagen.2006.07.017","article-title":"Cytochrome P450 systems--biological variations of electron transport chains","volume":"1770","author":"Hannemann","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"9","key":"10.1016\/j.jsbmb.2019.105507_bib0030","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1210\/jc.2016-2124","article-title":"Vitamin D-Dependent rickets type 1 caused by mutations in CYP27B1 affecting protein interactions with adrenodoxin","volume":"101","author":"Zalewski","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2019.105507_bib0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cbi.2006.06.008","article-title":"Mitochondrial P450s","volume":"163","author":"Omura","year":"2006","journal-title":"Chem. Biol. Interact."},{"issue":"18","key":"10.1016\/j.jsbmb.2019.105507_bib0040","article-title":"Bioactivity of curcumin on the cytochrome P450 enzymes of the steroidogenic pathway","volume":"20","author":"Rodriguez Castano","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.jsbmb.2019.105507_bib0045","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000500522","article-title":"HIV drug efavirenz inhibits CYP21A2 activity with possible clinical implications","volume":"91","author":"Malikova","year":"2019","journal-title":"Hormone Res. Paediatrics"},{"key":"10.1016\/j.jsbmb.2019.105507_bib0050","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jsbmb.2017.09.007","article-title":"CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2","volume":"174","author":"Malikova","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.jsbmb.2019.105507_bib0055","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbrc.2016.07.019","article-title":"Specificity of anti-prostate cancer CYP17A1 inhibitors on androgen biosynthesis","volume":"477","author":"Udhane","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105507_bib0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/bab.1099","article-title":"Contribution of cytochrome P450 to the diversification of eukaryotic organisms","volume":"60","author":"Omura","year":"2013","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"12","key":"10.1016\/j.jsbmb.2019.105507_bib0065","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1073\/pnas.83.12.4243","article-title":"Structure of a bovine gene for P-450c21 (steroid 21-hydroxylase) defines a novel cytochrome P-450 gene family","volume":"83","author":"Chung","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"23","key":"10.1016\/j.jsbmb.2019.105507_bib0070","doi-asserted-by":"crossref","first-page":"8962","DOI":"10.1073\/pnas.83.23.8962","article-title":"Human cholesterol side-chain cleavage enzyme, P450scc: cDNA cloning, assignment of the gene to chromosome 15, and expression in the placenta","volume":"83","author":"Chung","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jsbmb.2019.105507_bib0075","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1210\/endo-118-4-1296","article-title":"Study of cholesterol side-chain cleavage (20,22 desmolase) deficiency causing congenital lipoid adrenal hyperplasia using bovine-sequence P450scc oligodeoxyribonucleotide probes","volume":"118","author":"Matteson","year":"1986","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.jsbmb.2019.105507_bib0080","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.84.2.407","article-title":"Cytochrome P450c17 (steroid 17 alpha-hydroxylase\/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues","volume":"84","author":"Chung","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105507_bib0085","first-page":"52","article-title":"Assignment of the functional gene for human adrenodoxin to chromosome 11q13\u2013qter and of adrenodoxin pseudogenes to chromosome 20cen\u2013q13.1","volume":"43","author":"Morel","year":"1988","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.jsbmb.2019.105507_bib0090","doi-asserted-by":"crossref","DOI":"10.3390\/ph11020037","article-title":"Mechanism of the dual activities of human CYP17A1 and binding to anti-prostate Cancer drug abiraterone revealed by a novel V366M mutation causing 17,20 lyase deficiency","volume":"11","author":"Fernandez-Cancio","year":"2018","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.jsbmb.2019.105507_bib0095","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2265.2007.02948.x","article-title":"The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues","volume":"67","author":"Pepe","year":"2007","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105507_bib0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1530\/eje.1.02172","article-title":"Clinical and biochemical description of a novel CYP21A2 gene mutation 962_963insA using a new 3D model for the P450c21 protein","volume":"155","author":"Janner","year":"2006","journal-title":"Eur. J. Endocrinol."},{"issue":"9446","key":"10.1016\/j.jsbmb.2019.105507_bib0105","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(04)17344-3","article-title":"P450 oxidoreductase deficiency","volume":"364","author":"Miller","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jsbmb.2019.105507_bib0110","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/en.2016-1044","article-title":"The first defect in Electron transfer to mitochondrial P450 enzymes","volume":"157","author":"Miller","year":"2016","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.jsbmb.2019.105507_bib0115","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1210\/en.2005-0096","article-title":"Minireview: regulation of steroidogenesis by electron transfer","volume":"146","author":"Miller","year":"2005","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.jsbmb.2019.105507_bib0120","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ng1300","article-title":"Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome","volume":"36","author":"Fl\u00fcck","year":"2004","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.jsbmb.2019.105507_bib0125","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ymgme.2010.04.016","article-title":"Five novel mutations in CYP11B2 gene detected in patients with aldosterone synthase deficiency type I: functional characterization and structural analyses","volume":"100","author":"Nguyen","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105507_bib0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00682738","article-title":"Regulation of aromatase expression in human tissues","volume":"30","author":"Bulun","year":"1994","journal-title":"Breast Cancer Res. Treat."},{"issue":"9","key":"10.1016\/j.jsbmb.2019.105507_bib0135","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM199808273390905","article-title":"Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency","volume":"339","author":"Bilezikian","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2019.105507_bib0140","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1210\/jcem.87.6.8556","article-title":"Pituitary function in a man with congenital aromatase deficiency: effect of different doses of transdermal E2 on basal and stimulated pituitary hormones","volume":"87","author":"Rochira","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jsbmb.2019.105507_bib0145","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1210\/jc.2006-1181","article-title":"Variable phenotypes associated with aromatase (CYP19) insufficiency in humans","volume":"92","author":"Lin","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.jsbmb.2019.105507_bib0150","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000249159","article-title":"Genetic and clinical spectrum of aromatase deficiency in infancy, childhood and adolescence","volume":"72","author":"Belgorosky","year":"2009","journal-title":"Hormone Res."},{"issue":"6","key":"10.1016\/j.jsbmb.2019.105507_bib0155","first-page":"1287","article-title":"A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom)","volume":"78","author":"Conte","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105507_bib0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-2004-823023","article-title":"Aromatase: biologic relevance of tissue-specific expression","volume":"22","author":"Simpson","year":"2004","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.jsbmb.2019.105507_bib0165","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0006-291X(86)80477-6","article-title":"Purification to homogeneity of aromatase from human placenta","volume":"134","author":"Nakajin","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2019.105507_bib0170","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1016\/S0021-9258(18)61364-X","article-title":"Purification and characterization of human placental aromatase cytochrome P-450","volume":"262","author":"Kellis","year":"1987","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105507_bib0175","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/oxfordjournals.jbchem.a122213","article-title":"Novel properties of human placental aromatase as cytochrome P-450: purification and characterization of a unique form of aromatase","volume":"103","author":"Harada","year":"1988","journal-title":"J. Biochem. (Tokyo)"},{"issue":"7226","key":"10.1016\/j.jsbmb.2019.105507_bib0180","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nature07614","article-title":"Structural basis for androgen specificity and oestrogen synthesis in human aromatase","volume":"457","author":"Ghosh","year":"2009","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.jsbmb.2019.105507_bib0185","first-page":"4677","article-title":"Estrogen: consequences and implications of human mutations in synthesis and action","volume":"84","author":"Grumbach","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2019.105507_bib0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.steroids.2011.10.013","article-title":"Tissue physiology and pathology of aromatase","volume":"77","author":"Stocco","year":"2012","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105507_bib0195","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/bab.1088","article-title":"Human aromatase: perspectives in biochemistry and biotechnology","volume":"60","author":"Di Nardo","year":"2013","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.jsbmb.2019.105507_bib0200","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jsbmb.2017.01.002","article-title":"The steroid metabolite 16(beta)-OH-androstenedione generated by CYP21A2 serves as a substrate for CYP19A1","volume":"167","author":"Neunzig","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105507_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbapap.2003.10.003","article-title":"Electron transfer by diflavin reductases","volume":"1698","author":"Murataliev","year":"2004","journal-title":"Bba-Proteins Proteom"},{"issue":"2","key":"10.1016\/j.jsbmb.2019.105507_bib0210","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pharmthera.2013.01.010","article-title":"NADPH P450 oxidoreductase: structure, function, and pathology of diseases","volume":"138","author":"Pandey","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"13","key":"10.1016\/j.jsbmb.2019.105507_bib0215","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1021\/ja500054c","article-title":"Resonance Raman spectroscopy of the oxygenated intermediates of human CYP19A1 implicates a compound i intermediate in the final lyase step","volume":"136","author":"Mak","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"17","key":"10.1016\/j.jsbmb.2019.105507_bib0220","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1016\/j.febslet.2014.06.050","article-title":"Kinetic solvent isotope effect in steady-state turnover by CYP19A1 suggests involvement of Compound 1 for both hydroxylation and aromatization steps","volume":"588","author":"Khatri","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jsbmb.2019.105507_bib0225","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-3-319-16009-2_4","article-title":"Acyl-carbon bond cleaving cytochrome P450 enzymes: CYP17A1, CYP19A1 and CYP51A1","volume":"851","author":"Akhtar","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1-2","key":"10.1016\/j.jsbmb.2019.105507_bib0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mce.2014.03.008","article-title":"Characterization of a novel CYP19A1 (aromatase) R192H mutation causing virilization of a 46,XX newborn, undervirilization of the 46,XY brother, but no virilization of the mother during pregnancies","volume":"390","author":"Bouchoucha","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"issue":"12","key":"10.1016\/j.jsbmb.2019.105507_bib0235","first-page":"3689","article-title":"Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens","volume":"80","author":"Morishima","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105507_bib0240","first-page":"126","article-title":"Aromatase research and its clinical significance","volume":"61","author":"Czajka-Oraniec","year":"2010","journal-title":"Endokrynol. Pol."},{"issue":"6","key":"10.1016\/j.jsbmb.2019.105507_bib0245","first-page":"1739","article-title":"Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood","volume":"82","author":"Mullis","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.jsbmb.2019.105507_bib0250","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1515\/JPEM.1998.11.5.657","article-title":"Female pseudohermaphroditism associated with a novel homozygous G-to-A (V370-to-M) substitution in the P-450 aromatase gene","volume":"11","author":"Ludwig","year":"1998","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.jsbmb.2019.105507_bib0255","first-page":"4050","article-title":"Aromatase deficiency caused by a novel P450arom gene mutation: impact of absent estrogen production on serum gonadotropin concentration in a boy","volume":"84","author":"Deladoey","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105507_bib0260","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2003-030313","article-title":"Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment","volume":"89","author":"Maffei","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"19","key":"10.1016\/j.jsbmb.2019.105507_bib0265","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJMoa021559","article-title":"Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene","volume":"348","author":"Shozu","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jsbmb.2019.105507_bib0270","first-page":"1348","article-title":"The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription","volume":"83","author":"Stratakis","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Pt B","key":"10.1016\/j.jsbmb.2019.105507_bib0275","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jsbmb.2016.09.003","article-title":"Effect of sildenafil on human aromatase activity: from in vitro structural analysis to catalysis and inhibition in cells","volume":"165","author":"Baravalle","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105507_bib0280","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbapap.2017.05.013","article-title":"Identification of endocrine disrupting chemicals acting on human aromatase, Biochimica et biophysica acta","volume":"1866","author":"Baravalle","year":"2018","journal-title":"Proteins Proteomics"},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105507_bib0285","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/bab.1613","article-title":"Working at the membrane interface: ligand-induced changes in dynamic conformation and oligomeric structure in human aromatase","volume":"65","author":"Di Nardo","year":"2018","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"4","key":"10.1016\/j.jsbmb.2019.105507_bib0290","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ajmg.a.30169","article-title":"Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley-Bixler syndrome","volume":"128A","author":"Adachi","year":"2004","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.jsbmb.2019.105507_bib0295","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsbmb.2016.04.003","article-title":"P450 Oxidoreductase deficiency: analysis of mutations and polymorphisms","volume":"165","author":"Burkhard","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.105507_bib0300","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fphar.2014.00103","article-title":"Pharmacogenomics of human P450 oxidoreductase","volume":"5","author":"Pandey","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.jsbmb.2019.105507_bib0305","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ando.2014.03.002","article-title":"Steroidogenesis of the testis -- new genes and pathways","volume":"75","author":"Fl\u00fcck","year":"2014","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"10.1016\/j.jsbmb.2019.105507_bib0310","series-title":"Encyclopedia of Endocrine Diseases","first-page":"431","article-title":"Human P450 oxidoreductase deficiency","author":"Fl\u00fcck","year":"2019"},{"issue":"8","key":"10.1016\/j.jsbmb.2019.105507_bib0315","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/FPC.0b013e3283544062","article-title":"Effect of P450 oxidoreductase variants on the metabolism of model substrates mediated by CYP2C9.1, CYP2C9.2, and CYP2C9.3","volume":"22","author":"Subramanian","year":"2012","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.jsbmb.2019.105507_bib0320","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3389\/fphar.2017.00580","article-title":"Altered CYP19A1 and CYP3A4 activities due to mutations A115V, T142A, Q153R and P284L in the human P450 oxidoreductase","volume":"8","author":"Udhane","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"Pt A","key":"10.1016\/j.jsbmb.2019.105507_bib0325","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsbmb.2016.03.031","article-title":"Impact on CYP19A1 activity by mutations in NADPH cytochrome P450 oxidoreductase","volume":"165","author":"Fl\u00fcck","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"12","key":"10.1016\/j.jsbmb.2019.105507_bib0330","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1210\/jc.2016-1928","article-title":"P450 oxidoreductase deficiency: loss of activity caused by protein instability from a novel L374H mutation","volume":"101","author":"Parween","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jsbmb.2019.105507_bib0335","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.bbrc.2011.08.001","article-title":"Deletion of P399_E401 in NADPH cytochrome P450 oxidoreductase results in partial mixed oxidase deficiency","volume":"412","author":"Fl\u00fcck","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.jsbmb.2019.105507_bib0340","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1210\/me.2007-0245","article-title":"Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase","volume":"21","author":"Pandey","year":"2007","journal-title":"Mol. Endocrinol."},{"issue":"34","key":"10.1016\/j.jsbmb.2019.105507_bib0345","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1021\/bi400669h","article-title":"Structural basis for the functional roles of critical residues in human cytochrome p450 aromatase","volume":"52","author":"Lo","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.jsbmb.2019.105507_bib0350","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jsbmb.2016.09.022","article-title":"Impact of R264C and R264H polymorphisms in human aromatase function","volume":"167","author":"Baravalle","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.105507_bib0355","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-61737-967-3_7","article-title":"Efficient expression of human aromatase (CYP19) in E. Coli","volume":"705","author":"Kagawa","year":"2011","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"10.1016\/j.jsbmb.2019.105507_bib0360","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.steroids.2004.01.002","article-title":"Characterization of stable human aromatase expressed in E. Coli","volume":"69","author":"Kagawa","year":"2004","journal-title":"Steroids"},{"issue":"2","key":"10.1016\/j.jsbmb.2019.105507_bib0365","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0039-128X(02)00168-X","article-title":"Expression of human aromatase (CYP19) in Escherichia coli by N-terminal replacement and induction of cold stress response","volume":"68","author":"Kagawa","year":"2003","journal-title":"Steroids"},{"issue":"5","key":"10.1016\/j.jsbmb.2019.105507_bib0370","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1086\/429417","article-title":"Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis","volume":"76","author":"Huang","year":"2005","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.jsbmb.2019.105507_bib0375","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.mce.2010.02.024","article-title":"Restoration of mutant cytochrome P450 reductase activity by external flavin","volume":"321","author":"Nicolo","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"10.1016\/j.jsbmb.2019.105507_bib0380","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1073\/pnas.0711621105","article-title":"Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations","volume":"105","author":"Huang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.jsbmb.2019.105507_bib0385","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bbrc.2010.08.072","article-title":"Altered heme catabolism by heme oxygenase-1 caused by mutations in human NADPH cytochrome P450 reductase","volume":"400","author":"Pandey","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2019.105507_bib0390","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0076-6879(91)06116-K","article-title":"Assay of aromatase activity","volume":"206","author":"Lephart","year":"1991","journal-title":"Methods Enzymol"},{"issue":"12","key":"10.1016\/j.jsbmb.2019.105507_bib0395","doi-asserted-by":"crossref","first-page":"E1575","DOI":"10.1210\/jc.2015-3265","article-title":"IGHD II: A Novel GH-1 Gene Mutation (GH-L76P) Severely Affects GH Folding, Stability, and Secretion","volume":"100","author":"Miletta","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.jsbmb.2019.105507_bib0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046147","article-title":"Determining biophysical protein stability in lysates by a fast proteolysis assay, FASTpp","volume":"7","author":"Minde","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jsbmb.2019.105507_bib0405","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1021\/bi00355a036","article-title":"NADPH-cytochrome P-450 oxidoreductase: flavin mononucleotide and flavin adenine dinucleotide domains evolved from different flavoproteins","volume":"25","author":"Porter","year":"1986","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.jsbmb.2019.105507_bib0410","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1073\/pnas.0711621105","article-title":"Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations","volume":"105","author":"Huang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1187","key":"10.1016\/j.jsbmb.2019.105507_bib0415","article-title":"Variability in loss of multiple enzyme activities due to the human genetic variation P284T located in the flexible hinge region of NADPH cytochrome P450 oxidoreductase","volume":"10","author":"Parween","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.jsbmb.2019.105507_bib0420","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0163-7258(80)80020-9","article-title":"The history, properties, and function of NADPH-cytochrome P-450 reductase","volume":"9","author":"Masters","year":"1980","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.jsbmb.2019.105507_bib0425","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199707103370204","article-title":"Effect of testosterone and estradiol in a man with aromatase deficiency","volume":"337","author":"Carani","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.jsbmb.2019.105507_bib0430","doi-asserted-by":"crossref","first-page":"11673","DOI":"10.1073\/pnas.90.24.11673","article-title":"Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries","volume":"90","author":"Ito","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2019.105507_bib0435","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbrc.2019.05.127","article-title":"Variability in human drug metabolizing cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 activities caused by genetic variations in cytochrome P450 oxidoreductase","volume":"519","author":"Velazquez","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.jsbmb.2019.105507_bib0440","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/1873-3468.13360","article-title":"Crystal structure of a NADPH-cytochrome P450 oxidoreductase (CYPOR) and heme oxygenase 1 fusion protein implies a conformational change in CYPOR upon NADPH\/NADP+ binding","volume":"593","author":"Sugishima","year":"2019","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.jsbmb.2019.105507_bib0445","first-page":"823","article-title":"Modification of carboxyl groups on Nadph-Cytochrome-P-450 reductase involved in binding of Cytochromes-C and P-450 Lm2","volume":"14","author":"Bernhardt","year":"1987","journal-title":"Biochem. Int."},{"key":"10.1016\/j.jsbmb.2019.105507_bib0450","first-page":"320","article-title":"Molecular mechanism of Cytochrome-P-450 reductase interaction","author":"Bernhardt","year":"1989","journal-title":"Cytochrome P-450: Biochem. Biophys."},{"issue":"7","key":"10.1016\/j.jsbmb.2019.105507_bib0455","first-page":"581","article-title":"Electrostatic interactions between Cytochrome-P-450 Lm2 and Nadph-Cytochrome-P-450 reductase","volume":"47","author":"Bernhardt","year":"1988","journal-title":"Biomed. Biochim. Acta"},{"key":"10.1016\/j.jsbmb.2019.105507_bib0460","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-24922-x","article-title":"Direct observation of multiple conformational states in Cytochrome P450 oxidoreductase and their modulation by membrane environment and ionic strength","volume":"8","author":"Bavishi","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jsbmb.2019.105507_bib0465","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/dmd.117.078642","article-title":"Characterization of interactions among CYP1A2, CYP2B4, and NADPH-cytochrome P450 reductase: identification of specific protein complexes","volume":"46","author":"Connick","year":"2018","journal-title":"Drug Metab. Dispos."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076019303462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076019303462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:04:46Z","timestamp":1760745886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076019303462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":93,"alternative-id":["S0960076019303462"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2019.105507","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/664839","asserted-by":"object"}]},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential effects of variations in human P450 oxidoreductase on the aromatase activity of CYP19A1 polymorphisms R264C and R264H","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2019.105507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105507"}}